Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer
Titel:
Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer
Auteur:
Edelman, Martin J. Dvorkin, Mikhail Laktionov, Konstatin Navarro, Alejandro Juan-Vidal, Oscar Kozlov, Vadim Golden, Gil Jordan, Odette Deng, CQ Bentsion, Dmitriy Chouaid, Christos Dechev, Hristo Dowlati, Afshin Fernández Núñez, Natalia Ivashchuk, Olexandr Kiladze, Ivane Kortua, Tsira Leighl, Natasha Luft, Aleksandr Makharadze, Tamta Min, YoungJoo Quantin, Xavier